Hemopoietins and leukemia.
This article summarizes research relevant to the possible association between aberrant production of hemopoietins or hemopoietin-activated signals and the neoplastic growth of leukemic cells.
Demetri
G D
GD
Dana-Farber Cancer Institute, Boston, Massachusetts.
Griffin
J D
JD
D000208:Acute Disease; D001685:Biological Factors / Q000494:pharmacology / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D016207:Cytokines; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007942:Leukemia, Experimental / Q000235:genetics / Q000503:physiopathology; D007951:Leukemia, Myeloid / Q000503:physiopathology*; D008954:Models, Biological; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000473:pathology; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology; D011519:Proto-Oncogenes; D016186:Receptor, Macrophage Colony-Stimulating Factor; D011956:Receptors, Cell Surface / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D001685:Biological Factors; D016207:Cytokines; D011518:Proto-Oncogene Proteins; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; D016186:Receptor, Macrophage Colony-Stimulating Factor